GLP-1 warning letters to a firm of this name
Matched by name; FDA’s letter gives the address it was sent to.
GLP-1 recalls by a firm of this name
- Class II, ongoing, reported Oct 14, 2026Lack of Assurance of SterilityD-0036-2027 · Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC...
Matched by name, from FDA’s enforcement reports (updated by FDA Nov 11, 2026). Every GLP-1 recall
Source
Copied from FDA’s Registered Outsourcing Facilities table ↗, updated by FDA Nov 17, 2026, read Nov 18, 2026. The table does not include State Board of Pharmacy actions. All 100 registered facilities



